BrightOwl Loader Loading


I have extensive sales, marketing and leadership experience from national, regional and global positions in major, highly professional and well-recognised companies within Life Science.


My leadership approach is founded on trust, open dialogue and a collaborative approach to mutual success. Key strengths include the ability to set, develop and continuously motivate the right team – whether it is as part of the management team setting the direction for the whole company or developing my own division, sales- or marketing teams.


When it comes to sales and marketing I am told that I have a strong commercial focus combined with a clear sight for strategy development and execution. I have launched several new products and indications, build and commercialised new therapeutic areas, accelerated the growth of existing products and not least collaborated successfully with R&D on pipeline development to drive future growth.


I have a track record of creating solid results and have been describe as a motivating communicator capable of making significant impact on internal and external stakeholders. When it comes to business decisions they are always taken on the basis of customer insight, objective analysis of the facts at hand and a clear focus on driving the overall performance of the company more than individual or team performance.


Key strengths & personal competencies

• Leadership, incl. change & joint venture management

• Strategy development & execution (pipeline & inline)

• Market, brand & service development

• Sales force excellence

• Developing customer & stakeholder relationships

• Focus on achieving company and not only division, team or individual objectives

• Commercial, result oriented mind-set


Current Experience

  • Sr. Director, Global Commercial Lead, Head of Patient Solutions AK (Global Marketing) Denmark / Global responsebility
    Since October 2013

    Member of the Global Dermatology leadership team, Reports to VP of Global Patient Solutions (Global Marketing). Promoted from Director to Sr. Director May 2014.

    Member of LEO100 – the top leadership team in LEO Pharma.

    Global commercial lead for our franchise within skin cancer (AK & NMSC):

    • Accountable for the global, commercial strategy

    • Co-lead the ingenol asset management group (AMG) driving the long-term pipeline strategy

    • Provide commercial guidance to regions & markets

    • Provide commercial guidance to R&D ensuring development projects are founded on patient insights and fit for market needs

    • Support Business Development in ad hoc assessments

    • Lead, coach and develop the global patient solutions team (marketing) as well as the extended global brand team Direct reports: 5 (incl. 2 managers)

Past Experience

  • Director, Global Commercial Lead, Head of Patient Solutions AK (Global Marketing)
    October 2013 --- April 2014
    Member of the Global Dermatology leadership team, Reports to VP of Global Patient Solutions (Global Marketing) Promoted to Sr. Director May 2014 Global commercial lead for our franchise within skin cancer (AK & NMSC).

  • Head of Commercial Operations, Respiratory (Branded Generics & devices)
    March 2012 --- September 2013
    Member of the Nordic management team, Reported to the Nordic Country Head P & L responsibility for the respiratory product portfolio with the key task of establishing a new business unit in order to prepare for the launch of a number of first in class, branded generics with significant potential: • Develop the Nordic “go to market” strategy incl. organisational setup, market access & reimbursement, sales, marketing & medical / regulatory strategy • Business development & in-licensing • Establish Sandoz as a new player within the respiratory disease area (asthma, COPD) Team members: Initial increase from 0 to 12 employees within my team

  • Business Unit Director, Neuroscience & Business Operations
    August 2006 --- February 2012
    Promoted to Business Unit Director following MERCKs acquisition of Schering-Plough in Q4 2009. Member of the Danish leadership team. Reported to the General Manager of MSD Denmark. P & L responsibility for the Neuroscience portfolio & Diversified brands as well as a newly established strategic support organisation working across all business units. • Lead, coach & develop the team • Ensure the right strategy is developed & implemented for the department and through membership of the leadership team for the whole affiliate • Establish MSD as a new player within neuroscience through the launch of a new antipsychotic agent with significant potential • Develop a portfolio strategy for diversified brands • Develop a integrated strategic business support function, incl. multi channel marketing, project management (lean / six sigma), CRM, market research and event management Team members: 8 to 11 direct references and a total of 13 to 17 employees

  • Business Unit Manager, Primary Care (merged with MERCK)
    August 2006 --- December 2009
    Member of the Danish management team. Reported to the General Manager of Schering-Plough Denmark. Following MERCKs acquisition of Schering-Plough in Q4 2009 I was promoted to Business Unit Director within the new organisation (effective January 2010) P & L responsibility for the primary care portfolio focusing on allergy, cardiology, endocrinology & a large tail portfolio. • Lead, coach & develop the primary care team • Ensure the right strategy is developed & implemented for the department and through membership of the management committee for the whole affiliate • Maximizing the success of our joint venture with MSD • Cross-functional responsibility for market research, CRM management and general education in sales & marketing Team members: 6 direct references and a total team of 19 employees

  • Sr. Product Manager, Cardiometabolic disease / Obesity
    May 2005 --- July 2006
    Responsible for the pre-launch of Acomplia (rimonabant) expected to be the first blockbuster product after the merger of the two companies.

  • Brand Manager, CNS (Schizophrenia)
    April 2004 --- April 2005
    Responsible for marketing of Denmark’s largest antipsychotic Zyprexa (olanzapine) with a turnover of ~200 MDKK. Key focus was on the main indication schizophrenia, including forecasting, brand plan, budget & key opinion leader development as well as education and motivation of the sales force. Team members: Sales manager for 2 representatives and a marketing assistant

  • International Group Product Manager, Dermatology
    September 2002 --- March 2004
    Part of a team of 3-4 people having the overall responsibility for developing the international strategies for the psoriasis portfolio in addition to supporting, motivating and reviewing the performance of affiliates and regional offices.

  • Brand Manager, CNS (Bipolar & BPSD)
    December 1998 --- August 2002
    Responsible for marketing of Denmark’s largest antipsychotic Zyprexa (olanzapine). My responsibilities were primarily related to pre-launch and launch of two new indications, Bipolar disorder and treatment of Behavioural and Psychotic Symptoms of Dementia (BPSD).

  • Product Manager, Parkinson
    July 2000 --- April 2001
    Responsible for the promotion of Eli Lilly’s Parkinson drug, Permax (pergolid).

  • Sales representative
    December 1999 --- July 2000
    Gained a first hand impression of our customers and how to work with everything from canvas to key account management & district planning.

  • Marketing Associate
    December 1998 --- November 1999
    Successfully established a new market research and CRM function in the Danish organisation.

  • Marketing assistant
    August 1997 --- May 1998
    Part time job: • Different assignments in relation to planning and implementation of marketing campaigns • Participation in initiation and training of new agents, exhibits, demonstrations ect. • Sales support in relation to campaigns

  • Travel guide
    December 1995 --- April 1996
    Responsible for up to 180 Danish skiing tourists per week in Canazei, Italy


Self Assessment :
CommercializationInnovation Management
LinkedIn Assessment :
Cross-functional team leadershipStrategyProduct launchMarket accessSales EffectivenessPharmaceutical salesKey Account ManagementChange ManagementLeadershipmanagementSales ManagementSalesSales OperationsHospital SalesMarketing StrategyBusiness DevelopmentMarket researchMarket PlanningMarketingCRMForecastingGlobal MarketingMarketing ManagementMarket AnalysisBusiness StrategyDermatologyCardiologyEndocrinologyStrategic PlanningPipeline developmentPharmaceutical IndustryProject Management


  • Master of Science (M.Sc.) in International Marketing & Management from Copenhagen Business School in 1998
  • Bachelor (HA) in Economics, Business Administration & Languages from Syddansk Universitet in 1995
  • B.Sc. in Business Studies from Sheffield Hallam University in 1994
  • HH in Business Economics from Vejle Handelsskole in 1992
  • 10 klasses afgangseksamen in from Kirkebakkeskolen, Vejle (Primary & lower secondary school) in 1989
  • Executive course in Powering Growth from INSEAD in 0

Training and Certification

  • Masterclass in Digital transformation in 2017 Training
  • Leading Execution, Top100 program at LEO Pharma in 2016 Training
  • Powering Growth, Executive course at INSEAD in 2012 Training
  • Lean Six Sigma Executive Belt in 2011 Certification


BrightOwl Assessment:
Self Assessment:
Full Proficiency
Elementary Proficiency
Elementary Proficiency
Elementary Proficiency

Work Preferences

  • Notice Period:
    4 weeks
  • Positions I am interested in:
    General Manager Commercial lead Business unit lead Managing Director Sales and marketing lead Regional lead Global lead CEO CXO
  • Locations I am interested in:
    Denmark Sweden
  • Work From Home:
    Yes, 0 to 5 days per week
  • Work Regime:
    Permanent position
    BrightOwl freelancer
  • International:

Area / Region



Driving License
  • Yes